GBS NN

Drug Profile

GBS NN

Alternative Names: GBS vaccine - Minervax; Group B Streptococcal vaccine - Minervax; Streptococcal B vaccine - Minervax

Latest Information Update: 27 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Minervax
  • Class Streptococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Streptococcal infections

Most Recent Events

  • 01 Sep 2016 Minervax completes a phase-I trial in Streptococcal infections (Prevention) in United Kingdom (NCT02459262)
  • 11 Jun 2015 Immunogenicity data from preclinical trials in Streptococcal infections (Prevention) released by Minerva (Minerva pipeline, June 2015)
  • 31 May 2015 Phase-I clinical trials in Streptococcal infections (Prevention) in United Kingdom (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top